NovaBay Pharmaceuticals (NYSE:NBY) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of NovaBay Pharmaceuticals (NYSE:NBY – Free Report) in a research note published on Wednesday. The brokerage issued a sell rating on the stock. NovaBay Pharmaceuticals Price Performance NYSE:NBY opened at $0.47 on Wednesday. NovaBay Pharmaceuticals has a 52-week low of $0.42 and a 52-week high of $4.38. The firm has […]

Related Keywords

United States , ,Novabay Pharmaceuticals Price Performance ,Novabay Pharmaceuticals ,Novabay Pharmaceuticals Inc ,News Ratings For Novabay Pharmaceuticals Daily ,Free Report ,Bay Pharmaceuticals ,Get Free Report ,Avenova Spray ,Novabay Pharmaceuticals Daily ,Nyse Nby ,Anby ,Medical ,Initiated Coverage ,Stocknews Com ,